Growth Hormone & IGF-1 in Aging
The Rudman 1990 NEJM Study, Its Misuse, and GH-Abuse Risks
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Recombinant GH approved for specific deficiency states; prescribing GH for anti-aging/athletic enhancement is illegal under US law (FDCA distribution restrictions)
Reference only. Not medical advice.
What can go wrong
GH excess causes edema, arthralgia, carpal tunnel syndrome, gynecomastia, insulin resistance and overt hyperglycemia/diabetes, and, with chronic supraphysiologic use, features overlapping acromegaly. There are theoretical and epidemiologic concerns linking high IGF-1 to certain cancers. Black-market and counterfeit GH add contamination and dosing risk. US law specifically criminalizes GH distribution for non-approved (anti-aging, athletic) uses.
This is something to take to a clinician. The Atlas can tell you what is known about growth hormone & igf-1 in aging in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
The growth-hormone/IGF-1 axis declines with age ('somatopause'), and a single, much-cited study, Rudman et al. (NEJM 1990), reported that six months of GH in 12 healthy men over 60 raised lean body mass ~4.7 kg and cut fat mass ~3.5 kg. That body-composition cosmetic change was seized upon as proof of anti-aging rejuvenation. But the study showed NO improvement in strength or function, was small and uncontrolled for function, and follow-up work documented frequent adverse effects (gynecomastia, carpal tunnel, edema, insulin resistance/hyperglycemia). NEJM itself later published an editorial decrying the study's exploitation by anti-aging marketers. Distributing GH for anti-aging or athletic use is a federal crime in the US.
One small 1990 paper launched a multibillion-dollar anti-aging myth its own journal later disowned.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
Combinations named above are how people use these compounds together, under names the community gave them. The combinations themselves have not been studied. Evidence for one compound is not evidence for a pair.
How it is supposed to work
GH acts directly and via hepatic IGF-1 to promote nitrogen retention, lipolysis, and tissue growth. In aging, GH secretion and IGF-1 fall ('somatopause'). Replacing GH changes body composition (more lean mass, less fat) largely through fluid shifts and anabolic/lipolytic effects, but those compartment changes did not translate into functional strength gains in Rudman's cohort, the gap marketing ignores.
Body composition is not rejuvenation
Rudman's headline numbers measured compartments, not capability. Subsequent controlled work (e.g., Blackman et al., JAMA 2002) found GH +/- sex steroids in aging adults produced body-composition changes accompanied by frequent adverse effects and little functional benefit. Meanwhile, low IGF-1 is associated in some longevity research with LONGER life (the GH/IGF-1 axis is implicated in pro-aging signaling), so raising it may be counterproductive, the opposite of the marketed promise.
Safety in detail
This intervention involves significant physiological effects and requires evaluation and monitoring by a qualified physician. Growth hormone use for anti-aging or enhancement is illegal in the US and carries documented metabolic and oncologic risk concerns.
What has to be monitored
The bloodwork this needs, and the reason it belongs with a clinician rather than a website.
- IGF-1 levels
- Fasting glucose / HbA1c (diabetogenic risk)
- Signs of fluid retention, carpal tunnel, arthralgia
- Cancer surveillance per individual risk
What people get wrong
Often saidGH reverses aging (per Rudman 1990)
ActuallyRudman showed a cosmetic body-composition shift with no strength/function gain; NEJM later editorialized against marketers' misuse of the paper. Higher IGF-1 may even correlate with shorter life.
Often saidGH is a safe way to stay young and lean
ActuallyChronic GH raises edema, carpal tunnel, diabetes risk, and acromegaly-like changes; it is illegal to prescribe for anti-aging in the US.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
What we do not know
- Does the longevity association of LOW IGF-1 mean raising it accelerates aging?
- Is there any aging population in which GH improves function (not just composition) without unacceptable harm? (No convincing evidence.)
At a glance
- Origin study
- Rudman et al., NEJM 1990
- GH-treated men
- 12 (men over 60, low IGF-1)
- Duration
- 6 months
- Lean mass change
- +~4.7 kg
- Fat mass change
- -~3.5 kg
- Strength/function
- No demonstrated improvement
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Growth Hormone & IGF-1 in Aging. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Rudman et al., NEJM1990
GH in 12 men >60 raised lean mass ~4.7 kg and cut fat ~3.5 kg over 6 months; no functional/strength benefit shown
Papadakis / follow-up reports1990s
GH in older men associated with edema, carpal tunnel, gynecomastia, and impaired glucose tolerance, with minimal functional gain
Blackman et al., JAMA2002
GH and/or sex steroids in aging adults changed body composition but caused frequent adverse effects and limited functional improvement